Effect of polyvinylpyrrolidone included in polysulfone dialyzer on organisims.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1090220064

Enrollment

Registered

2011-07-01

Start date

2011-07-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patient

Interventions

Intervention type:PROCEDURE Name of intervention:Polyvinylpyrrolidone Dose form / Japanese Medical Device Nomenclature:OTHER Route of administration / Site of application:INTRADERMAL Dose per administ

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: person who doesn't have allergosis

Exclusion criteria

Exclusion criteria: Allergosis

Design outcomes

Primary

Measure	Time frame
Allergic sensitivity to PVP	—

Secondary

Measure	Time frame
Evaluation of skin by skin prick test and patch test. Evaluation by histamine release test.	—

Countries

Japan

Contacts

Public ContactShuji Konishi

Hattori Hospital

hattori2@mh1.117.ne.jp+81-794-82-2550

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026